Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1992 4
1993 6
1994 4
1995 6
1996 4
1997 9
1998 3
1999 2
2000 4
2001 9
2002 7
2003 7
2004 10
2005 11
2006 12
2007 6
2008 7
2009 2
2010 4
2011 5
2012 16
2013 12
2014 8
2015 4
2016 13
2017 8
2018 15
2019 9
2020 13
2021 9
2022 9
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Results by year

Filters applied: . Clear all
Page 1
Central neurocytoma.
Chen H, Zhou R, Liu J, Tang J. Chen H, et al. J Clin Neurosci. 2012 Jun;19(6):849-53. doi: 10.1016/j.jocn.2011.06.038. Epub 2012 Apr 25. J Clin Neurosci. 2012. PMID: 22537657
MR Finding of Extraventricular Neurocytoma.
Huang S, Liu X, Zhu J, Sun Z, Chen Y, Yu H. Huang S, et al. J Coll Physicians Surg Pak. 2022 Nov;32(11):1478-1482. doi: 10.29271/jcpsp.2022.11.1478. J Coll Physicians Surg Pak. 2022. PMID: 36377019
OBJECTIVE: To determine the MR (magnetic resonance), pathologic, and clinical findings of extraventricular neurocytoma (EVN). STUDY DESIGN: Descriptive study. PLACE AND DURATION OF STUDY: Department of Radiology, Affiliated Hospital of Jining Medical University, Jining, Sh …
OBJECTIVE: To determine the MR (magnetic resonance), pathologic, and clinical findings of extraventricular neurocytoma (EVN). STUDY D …
Pediatric Central Neurocytoma.
Karthigeyan M, Gupta K, Salunke P. Karthigeyan M, et al. J Child Neurol. 2017 Jan;32(1):53-59. doi: 10.1177/0883073816668994. Epub 2016 Sep 29. J Child Neurol. 2017. PMID: 27664193 Review.
A Clinicopathological and Molecular Analysis of Sellar/Suprasellar Neurocytoma Mimicking Pituitary Adenoma.
Zhang L, Fu W, Zheng L, Song F, Chen Y, Jiang C, Xing Z, Hu C, Ye Y, Zhang S, Yan X, Wang X. Zhang L, et al. Front Endocrinol (Lausanne). 2022 May 18;13:861540. doi: 10.3389/fendo.2022.861540. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35663322 Free PMC article.
OBJECTIVE: To investigate the clinicopathological characteristics, molecular genetic characteristics and prognosis of extraventricular neurocytoma located in the sellar/suprasellar region. METHODS: Seven archived tumor samples derived from 4 patients with neurocytoma …
OBJECTIVE: To investigate the clinicopathological characteristics, molecular genetic characteristics and prognosis of extraventricular ne …
Extraventricular neurocytoma, a comprehensive review.
Patil AS, Menon G, Easwer HV, Nair S. Patil AS, et al. Acta Neurochir (Wien). 2014 Feb;156(2):349-54. doi: 10.1007/s00701-013-1971-y. Epub 2013 Dec 20. Acta Neurochir (Wien). 2014. PMID: 24357019 Review.
The management of residual or recurrent central neurocytoma.
Thawani JP, Lee JY. Thawani JP, et al. Neurosurg Clin N Am. 2015 Jan;26(1):67-81. doi: 10.1016/j.nec.2014.09.002. Neurosurg Clin N Am. 2015. PMID: 25432185 Review.
Treatment following neurosurgical resection or biopsy of a central neurocytoma depends on the pathologic analysis and proliferative activity demonstrated, the extent of surgical resection, the neuroanatomic location and accessibility of residual tumor, and the patient's po …
Treatment following neurosurgical resection or biopsy of a central neurocytoma depends on the pathologic analysis and proliferative a …
Molecular characterization of histopathological ependymoma variants.
Neumann JE, Spohn M, Obrecht D, Mynarek M, Thomas C, Hasselblatt M, Dorostkar MM, Wefers AK, Frank S, Monoranu CM, Koch A, Witt H, Kool M, Pajtler KW, Rutkowski S, Glatzel M, Schüller U. Neumann JE, et al. Acta Neuropathol. 2020 Feb;139(2):305-318. doi: 10.1007/s00401-019-02090-0. Epub 2019 Nov 2. Acta Neuropathol. 2020. PMID: 31679042
Instead, they were classified as low-grade glioma (n = 3), plexus tumor (n = 2), CNS high-grade neuroepithelial tumor with MN1 alteration (n = 2), papillary tumor of the pineal region (n = 2), neurocytoma (n = 1), or did not match to any known brain tumor methylation class …
Instead, they were classified as low-grade glioma (n = 3), plexus tumor (n = 2), CNS high-grade neuroepithelial tumor with MN1 alteration (n …
FGFR- gene family alterations in low-grade neuroepithelial tumors.
Bale TA. Bale TA. Acta Neuropathol Commun. 2020 Feb 21;8(1):21. doi: 10.1186/s40478-020-00898-6. Acta Neuropathol Commun. 2020. PMID: 32085805 Free PMC article. Review.
In this review, recent evidence for recurrent FGFR alterations in histologically and biologically low-grade neuroepithelial tumors (LGNTs) is examined (namely FGFR1 tyrosine kinase domain duplication in low grade glioma, FGFR1-TACC1 fusions in extraventricular neurocytoma …
In this review, recent evidence for recurrent FGFR alterations in histologically and biologically low-grade neuroepithelial tumors (LGNTs) i …
Immunohistochemical expression of Olig2, CD99, and EMA to differentiate oligodendroglial-like neoplasms.
Kurdi M, Eberhart C. Kurdi M, et al. Folia Neuropathol. 2021;59(3):284-290. doi: 10.5114/fn.2021.108526. Folia Neuropathol. 2021. PMID: 34628794 Free article.
Olig2 is a specific IHC marker to diagnose oligodendroglioma and differentiate it from ependymoma and central neurocytoma. Lack of Olig2 expression rules out oligodendroglioma and suggests the diagnosis of ependymoma rather than central neurocytoma if the EMA labell …
Olig2 is a specific IHC marker to diagnose oligodendroglioma and differentiate it from ependymoma and central neurocytoma. Lack of Ol …
211 results